Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Controlled Study Comparing Iron Sucrose Intravenously to No Iron Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy

NCT00236951 is registered in ClinicalTrials.gov with American Regent, Inc. as lead sponsor.

NCT NCT00236951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00236951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Controlled Study Comparing Iron Sucrose Intravenously to No Iron Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy
Lead sponsor
American Regent, Inc.
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2003
Completion date
December 31, 2005
Enrollment
224 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia